Despite the absence of any apparent adverse health effects of whole-body deletion of both NT5C1A and NTC2 in our mouse model, the presence of auto-antibodies against NT5C1A was linked to (dermato)myositis (33) while its overexpression in pancreatic cancer was linked to chemotherapy resistance (34). Here, NT5C1A is linked to myositis disease.